NxStage Medical (NSDQ:NXTM) named Robert Funari to replace Philippe Chambon as non-executive chairman after 15 years on the medical device company’s board of directors.

Lawrence, Mass.-based NxStage said Funari’s resume includes stints as chairman of Crescent Healthcare and executive roles at Beckman Coulter, Pope & Talbot, First Consulting Group and Bay Cities National Bank. He is currently a member of the RAND Healthcare Board of Advisors, according to a press release.

"We are very grateful to Philippe for his significant contributions to NxStage, commencing with our formation in 1998, and for the continued strategic guidance and valuable service he has given to the company during his time as chairman," founder & CEO Jeffrey Burbank said in prepared remarks.

 Senate votes in new Office of Management & Budget director
New director of OMB Sylvia Mathews Burwell will replace Jeffrey Zients after the U.S. Senate confirmed her nomination on a 96-0 vote. President Barack Obama called Burwell, who will oversee the agency’s budget, programs and policies, a "key member of my economic team."
Read more

 New COO at Pro-Dex

Pro-Dex (NSDQ:PDEX) promoted Richard Van Kirk Jr. to chief operating officer from vice president of operations.
Read more

 SurgiCount Medical hires product management VP

SurgiCount, a subsidiary of Patient Safety Technologies (OTC:PSTX), appointed Michael Roux vice president of product management. Roux will join SurgiCount from his former position as product director for the global respiratory franchise at Hill-Rom (NYSE:HRC).
 
Read more

 Cooley adds to life science regulatory practice

Law firm Cooley LLP hired Wendy Goldstein as a new partner in its healthcare and life sciences regulatory practice. Goldstein was a partner at Epstein Becker & Green.
Read more